Citation Impact
Citing Papers
A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101
2012
Acquired Resistance to BET-PROTACs (Proteolysis-Targeting Chimeras) Caused by Genomic Alterations in Core Components of E3 Ligase Complexes
2019
Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma
2011
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Novel Therapeutic Strategy to Prevent Chemotherapy-Induced Persistent Sensory Neuropathy By TRPA1 Blockade
2013
Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database
2002
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer
2016 StandoutNobel
Head and neck squamous cell carcinoma
2020 Standout
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Chemotherapy-induced neuropathy: A comprehensive survey
2014
The multitude and diversity of environmental carcinogens
2007 StandoutNobel
The epidemiology of human papillomavirus infections
2005
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasia
2004
HPV-mediated transformation of the anogenital tract
2005
Global Cancer Statistics, 2002
2005 Standout
Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas
2001
Regulation and Functions of the ER-Associated Nrf1 Transcription Factor
2022 StandoutNobel
Genome‐wide profiling of chromosomal alterations in renal cell carcinoma using high‐density single nucleotide polymorphism arrays
2009
Human papillomavirus variants and squamous neoplasia of the cervix
2001
The emerging role of lncRNAs in cancer
2015 Standout
NUCLEOTIDE EXCISION REPAIR
1993 StandoutNobel
The Human Papillomavirus E6 protein and its contribution to malignant progression
2001
Long Noncoding RNAs in Cancer Pathways
2016 Standout
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
2008 Standout
The molecular biology of head and neck cancer
2010 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human Papillomavirus
2004
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
2011
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
2021 StandoutNobel
Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays
2003
Skin Cancers after Organ Transplantation
2003 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Colorectal cancer
2019 Standout
The causal relation between human papillomavirus and cervical cancer
2002 Standout
PVT1 dependence in cancer with MYC copy-number increase
2014 Nature
Human papillomavirus and cervical cancer
2007 Standout
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Combined human papillomavirus DNA and human papillomavirus‐like particle serologic assay to identify women at risk for high‐grade cervical intraepithelial neoplasia
2006
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Human Papillomavirus Type 16 Variants and Risk of Cervical Cancer
2001
The natural history of cervical HPV infection: unresolved issues
2006
Switching and Signaling at the Telomere
2001 StandoutNobel
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Human Papillomavirus Types 16 E6 and E7 Contribute Differently to Carcinogenesis
2000
Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study
2003 Standout
Shank-interacting protein–like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells
2010
Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trial
2003
The biogenesis, biology and characterization of circular RNAs
2019 Standout
The molecular landscape of head and neck cancer
2018 Standout
Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity
2024 StandoutNobel
New cancer targets emerging from studies of the Von Hippel‐Lindau tumor suppressor protein
2010 StandoutNobel
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial
2006
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment
2011
Heritability of cervical tumours
2000
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
TP53 Polymorphism of Exon 4 at Codon 72 in Cutaneous Squamous Cell Carcinoma and Benign Epithelial Lesions of Renal Transplant Recipients and Immunocompetent Individuals: Lack of Correlation with Human Papillomavirus Status11This work was presented in part at the 19th International Papillomavirus Conference in Florianopolis, Brazil, September 1–7, 2001.
2002
Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies
2018
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients
2006
Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers
2008 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Relationship Between p53 Codon 72 Polymorphism and Susceptibility to Sunburn and Skin Cancer
2002
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21
2015 StandoutNobel
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
2013
Oncogenic Human Papillomavirus DNA Loads in Human Immunodeficiency Virus-Positive Women with High-Grade Cervical Lesions Are Strongly Elevated
2003
Cellular Resistance Mechanisms to Targeted Protein Degradation Converge Toward Impairment of the Engaged Ubiquitin Transfer Pathway
2019
Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses
2011 StandoutNobel
Peptidic degron for IMiD-induced degradation of heterologous proteins
2019 StandoutNobel
Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites
2016
How relevant is the Escherichia coli uvrabc model for excision repair in eukaryotes?
1991
Immortalization of Human CD8+ T Cell Clones by Ectopic Expression of Telomerase Reverse Transcriptase
2000
The role of microRNA genes in papillary thyroid carcinoma
2005 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Resistance to proteasome inhibitors and other targeted therapies in myeloma
2018
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals
1999
Human Papillomavirus and Cervical Cancer
2003 Standout
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Relationships of Human Papillomavirus Type, Qualitative Viral Load, and Age with Cytologic Abnormality
2006
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions.
2003
Works of Mark van Duin being referenced
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma
2016
High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas
2007
Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
2010
Construction and application of a full‐coverage, high‐resolution, human chromosome 8q genomic microarray for comparative genomic hybridization
2004
Telomerase activity in high‐grade cervical lesions is associated with allelic imbalance at 6Q14–22
2003
Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix
2001
The cloned human DNA excision repair gene ERCC-1 fails to correct xeroderma pigmentosum complementation groups A through I
1989
HPV 16 infection and progression of cervical intra-epithelial neoplasia: Analysis of HLA polymorphism and HPV 16 E6 sequence variants
1998
Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin‐dependent kinase 6 at both genomic and protein expression levels
2008
Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance
2002
The myeloma stem cell concept, revisited: from phenomenology to operational terms
2016
High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
2012
Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis
2000
Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
1998